183 related articles for article (PubMed ID: 31100710)
1. PRDM1 levels are associated with clinical diseases in chronic HBV infection and survival of patients with HBV-related hepatocellular carcinoma.
Li N; Fan X; Wang X; Deng H; Zhang K; Zhang X; Wang Y; Han Q; Lv Y; Liu Z
Int Immunopharmacol; 2019 Aug; 73():156-162. PubMed ID: 31100710
[TBL] [Abstract][Full Text] [Related]
2. Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.
Li N; Zhou Z; Li F; Sang J; Han Q; Lv Y; Zhao W; Li C; Liu Z
Oncotarget; 2017 Jul; 8(28):46020-46033. PubMed ID: 28545019
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma.
Li N; Zhu Q; Yang C; Li F; Zhou Z; Lv Y; Sang J; Han Q; Liu Z
Tumour Biol; 2016 May; 37(5):6607-17. PubMed ID: 26643893
[TBL] [Abstract][Full Text] [Related]
4. PRDM1 rs1010273 polymorphism is associated with overall survival of patients with hepatitis B virus-related hepatocellular carcinoma.
Li N; Fan X; Wang X; Deng H; Zhang K; Zhang X; Han Q; Lv Y; Liu Z
Immunol Lett; 2019 Sep; 213():39-45. PubMed ID: 31376415
[TBL] [Abstract][Full Text] [Related]
5. Genetic association of polymorphisms at the intergenic region between PRDM1 and ATG5 with hepatitis B virus infection in Han Chinese patients.
Li N; Fan X; Wang X; Zhang X; Zhang K; Han Q; Lv Y; Liu Z
J Med Virol; 2020 Aug; 92(8):1198-1205. PubMed ID: 31729038
[TBL] [Abstract][Full Text] [Related]
6. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
[TBL] [Abstract][Full Text] [Related]
8. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
[TBL] [Abstract][Full Text] [Related]
9. Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.
Lin YJ; Lee MH; Yang HI; Jen CL; You SL; Wang LY; Lu SN; Liu J; Chen CJ
PLoS One; 2013; 8(4):e61448. PubMed ID: 23613855
[TBL] [Abstract][Full Text] [Related]
10. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP
BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833
[TBL] [Abstract][Full Text] [Related]
11. What can we learn from hepatitis B virus clinical cohorts?
Lin CL; Tseng TC; Kao JH
Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of B-cell activating factor in chronic hepatitis B virus infection: association with clinical diseases.
Yang C; Li N; Wang Y; Zhang P; Zhu Q; Li F; Han Q; Lv Y; Yu L; Wei P; Liu Z
J Interferon Cytokine Res; 2014 Oct; 34(10):787-94. PubMed ID: 24811691
[TBL] [Abstract][Full Text] [Related]
13. IL-23 production of liver inflammatory macrophages to damaged hepatocytes promotes hepatocellular carcinoma development after chronic hepatitis B virus infection.
Zang M; Li Y; He H; Ding H; Chen K; Du J; Chen T; Wu Z; Liu H; Wang D; Cai J; Qu C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3759-3770. PubMed ID: 30292634
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.
Li L; Guo Z; Wang J; Mao Y; Gao Q
Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399
[TBL] [Abstract][Full Text] [Related]
15. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV.
Lu J; Xie F; Geng L; Shen W; Sui C; Yang J
Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706
[TBL] [Abstract][Full Text] [Related]
16. Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study.
Wang R; Zang W; Hu B; Deng D; Ling X; Zhou H; Su M; Jiang J
Technol Cancer Res Treat; 2020; 19():1533033820980785. PubMed ID: 33308056
[TBL] [Abstract][Full Text] [Related]
17. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
[TBL] [Abstract][Full Text] [Related]
18. Low Frequency of Peripheral Lymphocyte in Chronic Hepatitis B Patients Predicts Poor Progression to Hepatocellular Carcinoma.
Li J; Li J; Bao Y; Pan K; Lin X; Liu X; Wang H; Xu Y; Luo X; Li H; Duan C
J Clin Lab Anal; 2016 May; 30(3):208-15. PubMed ID: 25600684
[TBL] [Abstract][Full Text] [Related]
19. Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.
Tong HV; Song le H; Hoan NX; Cuong BK; Sy BT; Son HA; Quyet D; Binh VQ; Kremsner PG; Bock CT; Velavan TP; Toan NL
BMC Infect Dis; 2015 Jan; 15():25. PubMed ID: 25626490
[TBL] [Abstract][Full Text] [Related]
20. The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection.
Sheng T; Wang B; Wang SY; Deng B; Qu L; Qi XS; Wang XL; Deng GL; Sun X
Medicine (Baltimore); 2015 Jun; 94(24):e941. PubMed ID: 26091457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
